Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 27, 2022, Rafael G. Amado, M.D., the Executive Vice President of Research and Development of Allogene Therapeutics, Inc. (the "Company"), notified the Company of his decision to resign, effective December 30, 2022, to pursue another opportunity.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses